1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Antibody Drug Conjugates Market Size Growth Rate by Type (2020-2025)
1.3.2 Adcetris
1.3.3 Kadcyla
1.4 Market Segment by Application
1.4.1 Global Antibody Drug Conjugates Market Share by Application (2020-2025)
1.4.2 Breast Cancer
1.4.3 Lymphoma
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antibody Drug Conjugates Market Size
2.1.1 Global Antibody Drug Conjugates Revenue 2015-2025
2.1.2 Global Antibody Drug Conjugates Sales 2015-2025
2.2 Antibody Drug Conjugates Growth Rate by Regions
2.2.1 Global Antibody Drug Conjugates Sales by Regions 2015-2019
2.2.2 Global Antibody Drug Conjugates Revenue by Regions 2015-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Antibody Drug Conjugates Sales by Manufacturers
3.1.1 Antibody Drug Conjugates Sales by Manufacturers 2015-2019
3.1.2 Antibody Drug Conjugates Sales Market Share by Manufacturers 2015-2019
3.2 Revenue by Manufacturers
3.2.1 Antibody Drug Conjugates Revenue by Manufacturers (2015-2019)
3.2.2 Antibody Drug Conjugates Revenue Share by Manufacturers (2015-2019)
3.2.3 Global Antibody Drug Conjugates Market Concentration Ratio (CR5 and HHI)
3.3 Antibody Drug Conjugates Price by Manufacturers
3.4 Key Manufacturers Antibody Drug Conjugates Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Antibody Drug Conjugates Market
3.6 Key Manufacturers Antibody Drug Conjugates Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Adcetris Sales and Revenue (2015-2019)
4.1.2 Kadcyla Sales and Revenue (2015-2019)
4.2 Global Antibody Drug Conjugates Sales Market Share by Type
4.3 Global Antibody Drug Conjugates Revenue Market Share by Type
4.4 Antibody Drug Conjugates Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Antibody Drug Conjugates Sales by Application
6 United States
6.1 United States Antibody Drug Conjugates Breakdown Data by Company
6.2 United States Antibody Drug Conjugates Breakdown Data by Type
6.3 United States Antibody Drug Conjugates Breakdown Data by Application
7 European Union
7.1 European Union Antibody Drug Conjugates Breakdown Data by Company
7.2 European Union Antibody Drug Conjugates Breakdown Data by Type
7.3 European Union Antibody Drug Conjugates Breakdown Data by Application
8 China
8.1 China Antibody Drug Conjugates Breakdown Data by Company
8.2 China Antibody Drug Conjugates Breakdown Data by Type
8.3 China Antibody Drug Conjugates Breakdown Data by Application
9 Rest of World
9.1 Rest of World Antibody Drug Conjugates Breakdown Data by Company
9.2 Rest of World Antibody Drug Conjugates Breakdown Data by Type
9.3 Rest of World Antibody Drug Conjugates Breakdown Data by Application
9.4 Rest of World Antibody Drug Conjugates Breakdown Data by Countries
9.4.1 Rest of World Antibody Drug Conjugates Sales by Countries
9.4.2 Rest of World Antibody Drug Conjugates Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 F. Hoffman-La Roche
10.1.1 F. Hoffman-La Roche Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Antibody Drug Conjugates
10.1.4 Antibody Drug Conjugates Product Introduction
10.1.5 F. Hoffman-La Roche Recent Development
10.2 Novartis AG
10.2.1 Novartis AG Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Antibody Drug Conjugates
10.2.4 Antibody Drug Conjugates Product Introduction
10.2.5 Novartis AG Recent Development
10.3 Takeda Pharmaceutical
10.3.1 Takeda Pharmaceutical Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Antibody Drug Conjugates
10.3.4 Antibody Drug Conjugates Product Introduction
10.3.5 Takeda Pharmaceutical Recent Development
10.4 Pfizer
10.4.1 Pfizer Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Antibody Drug Conjugates
10.4.4 Antibody Drug Conjugates Product Introduction
10.4.5 Pfizer Recent Development
10.5 Seattle Genetics
10.5.1 Seattle Genetics Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Antibody Drug Conjugates
10.5.4 Antibody Drug Conjugates Product Introduction
10.5.5 Seattle Genetics Recent Development
10.6 Genentech
10.6.1 Genentech Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Antibody Drug Conjugates
10.6.4 Antibody Drug Conjugates Product Introduction
10.6.5 Genentech Recent Development
10.7 Immunogen
10.7.1 Immunogen Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Antibody Drug Conjugates
10.7.4 Antibody Drug Conjugates Product Introduction
10.7.5 Immunogen Recent Development
10.8 Progenics Pharmaceuticals
10.8.1 Progenics Pharmaceuticals Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Antibody Drug Conjugates
10.8.4 Antibody Drug Conjugates Product Introduction
10.8.5 Progenics Pharmaceuticals Recent Development
10.9 Bayer Healthcare Pharmaceuticals
10.9.1 Bayer Healthcare Pharmaceuticals Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Antibody Drug Conjugates
10.9.4 Antibody Drug Conjugates Product Introduction
10.9.5 Bayer Healthcare Pharmaceuticals Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Antibody Drug Conjugates Sales Channels
11.2.2 Antibody Drug Conjugates Distributors
11.3 Antibody Drug Conjugates Customers
12 Market Forecast
12.1 Global Antibody Drug Conjugates Sales and Revenue Forecast 2020-2025
12.2 Global Antibody Drug Conjugates Sales Forecast by Type
12.3 Global Antibody Drug Conjugates Sales Forecast by Application
12.4 Antibody Drug Conjugates Forecast by Regions
12.4.1 Global Antibody Drug Conjugates Sales Forecast by Regions 2020-2025
12.4.2 Global Antibody Drug Conjugates Revenue Forecast by Regions 2020-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
